drugset
drugset / Trial / NCT01357421

Effects of TT301 on Cytokine Levels Post Endotoxin Challenge

NCT01357421 ↗

Phase 1 Completed 18 enrolled OPKO Health, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effects of TT301 on cytokine levels in healthy male volunteers participating in an endotoxin challenge.

Timeline

Start
2011-05
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Subject TT301 Small molecule — Intravenous

Indications

traumatic brain injury